- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT03155750
Effects of Zero-Time Exercise (ZTEx) on Inactive Adults With Insomnia
Effects of Zero-Time Exercise (ZTEx) on Inactive Adults With Insomnia: A Pilot Randomized Controlled Trial
Objectives: To evaluate the clinical effects of Zero-Time Exercise (ZTEx) for treating insomnia disorder delivered by a training course.
Hypothesis: Subjects in the ZTEx training group will have greater improvement in insomnia symptoms and daytime impairment than those in the sleep hygiene education (SHE) group at week 8.
Design and subjects: A randomized controlled trial. 32 inactive subjects with insomnia disorder recruited from the community will be randomized to ZTEx training or SHE groups in a 1: 1 ratio.
Study instrument: Insomnia Severity Index (ISI) will be used to assess insomnia symptoms and daytime impairment.
Interventions: Subjects in the ZTEx training group will attend two training lessons (2-hour each) to learn ZTEx and practice it every night for 8 weeks; subjects in the SHE group will receive sleep hygiene education with the schedule and duration that are same to the ZTEx training group.
Main outcome measures: The primary outcome measure is the ISI score. Other measures include sleep parameters by subjective sleep diary and objective actigraphy, Hospital Anxiety and Depression Scale, Multidimensional Fatigue Inventory-20 and Short Form-6 Dimension. Acceptability and compliance of ZTEx will be evaluated.
Data Analysis: Differences in the questionnaire scores, subjective and objective sleep parameters will be examined using a mixed-effects model.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
-
Hong Kong, Hong Kong
- School of Nursing, The Hong Kong Polytechnic University
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Adults age 18-65 years old;
- Chinese Hong Kong residents who are able to communicate in Cantonese or Mandarin;
- A current clinical Diagnostic and Statistical Manual of Mental Disorders-fifth edition (DSM-5) diagnosis of insomnia disorder (Primary in nature) according to the Brief Insomnia Questionnaire (BIQ), a validated diagnostic tool. The criteria include having difficulties in falling asleep, difficulties in staying asleep, or early morning awakening with clinically significant consequences for daily life for at least 3 months;
- Insomnia Severity Index total score of at least 10 indicating insomnia at the clinical level;
- Willing to give informed consent and comply with the trial protocol;
- Ambulant and independent in activities of daily living;
- Physically inactive which refers to less than 150 minutes moderate-intensity activity per week or less than 75 minutes vigorous-intensity activity per week, or an equivalent combination of moderate- and vigorous- intensity activity.
Exclusion Criteria:
- Evidence of association of insomnia with medical conditions, other sleep disorders, or side-effects of medications;
- Use of medication or psychotherapeutic components for insomnia or other psychiatric disorders;
- Other possible psychiatric disorders including generalized anxiety disorder (GAD), major depressive disorder (MDD), posttraumatic stress disorder (PTSD), psychosis as screened by structural clinical interview of DSM-IV;
- cognitive impairment preventing informed consent or understanding of instructions (score < 22 in Montreal Cognitive Assessment Hong Kong version);
- Shift work;
- body mass index equal to or over 27.5, the obese criteria for Asians;
- Unsafe conditions or incapable to exercise as recommended by their physician.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Seul
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Zero Time Exercise training
Subjects in this group will attend two 2-hour ZTEx training lessons.
Each subject will receive a handout and an exercise log.
The handout includes a picture-illustrating ZTEx step-by-step protocol.
The exercise log is for them to record their time spending on performing the ZTEx every day during the 8-week study period.
|
Zero Time Exercise encourage les gens à augmenter l'exercice physique par des mouvements simples qui peuvent être effectués à tout moment et en tout lieu.
Nous proposons une formation en 2 séances pour entraîner les sujets à faire de l'exercice en temps zéro.
|
|
Comparateur actif: sleep hygiene education
Subjects in this group will receive two 2-hour lessons of sleep hygiene education delivered by a registered nurse.
|
Nous proposons un cours de formation en 2 sessions pour enseigner aux sujets les pratiques d'hygiène du sommeil.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Insomnia Severity Index
Délai: week 8
|
The subjects rate the severity of insomnia, the distress, and the functional impairment associated with insomnia on a 5-point
|
week 8
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Sleep diary (7-day)
Délai: Baseline, week 4, week 8
|
The standardized sleep diary records the daily bedtime and rising time, from which the total time in bed (TIB) can be calculated.
|
Baseline, week 4, week 8
|
|
Multidimensional fatigue inventory-20
Délai: Baseline, week 4, week 8
|
Multidimensional fatigue inventory-20 is a 20-items self-report instrument designed to measure severity of fatigue.
|
Baseline, week 4, week 8
|
|
Hospital Anxiety and Depression Scale
Délai: Baseline, week 4, week 8
|
The Hospital Anxiety and Depression Scale is a 14-items self-administered questionnaire, which assesses the severity of depressive and anxiety symptoms
|
Baseline, week 4, week 8
|
|
Actigraphy (7-day)
Délai: Baseline, week 8
|
Actigraphy measures wrist movements to assess sleep or waking state, is accomplished through an accelerometer in a wrist worn device
|
Baseline, week 8
|
|
Short Form-6 Dimension
Délai: Baseline, week 4, week 8
|
The Short Form-6 Dimension is composed of six multi-level dimensions to assess the quality of life which can be used in cost-utility analysis.
|
Baseline, week 4, week 8
|
|
Hand grip strength
Délai: Baseline, week 8
|
Objective hand grip strength
|
Baseline, week 8
|
|
Level of activity
Délai: Baseline, week4, week 8
|
Self-report level of activity in moderate and vigorous intensity
|
Baseline, week4, week 8
|
|
Weight
Délai: Baseline, week 8
|
Weight in kilograms; (Weight and Height will be combined to report as BMI in kg/m^2)
|
Baseline, week 8
|
|
Height
Délai: Baseline, week 8
|
Height in meters; (Weight and Height will be combined to report as BMI in kg/m^2)
|
Baseline, week 8
|
Collaborateurs et enquêteurs
Parrainer
Publications et liens utiles
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- ZTEInsomnia
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .
Essais cliniques sur Insomnie primaire
-
Jiangsu HengRui Medicine Co., Ltd.RecrutementHER2-positif Primary Breast Cancer Cancer participants atteints d'une maladie invasive résiduelle après un traitement néoadjuvantChine
Essais cliniques sur Exercice de temps zéro
-
The Hong Kong Polytechnic UniversityComplétéInsomnie primaireHong Kong
-
GE HealthcareComplétéImagerie cérébrale | Imagerie du corps entierÉtats-Unis
-
University of RijekaPharmamedMado d.o.o., Zagreb, CroatiaInconnueHypothermie | Signes et symptômes | Hémorragie intracérébrale primaireCroatie
-
Shanghai First Maternity and Infant HospitalInconnueEmbryon de qualité supérieureChine
-
Synthes USA HQ, Inc.Résilié
-
Aalborg University HospitalLund University; Catholic University of the Sacred Heart; University of Lausanne... et autres collaborateursInconnueDouleur du membre fantômeDanemark
-
University of TorontoMarch of Dimes, CanadaComplétéLimitation de la mobilité | Altération de l'équilibreCanada
-
Rigshospitalet, DenmarkNorthwestern University Feinberg School of Medicine; University Hospital BirminghamComplétéHypertension intracrânienne | Insuffisance hépatique aiguëÉtats-Unis, Danemark, Royaume-Uni
-
Medical College of WisconsinPas encore de recrutementDiabète de type 1 | Diabète sucré de type 1 | diabète de type 1 | Édulcorant non nutritifÉtats-Unis
-
Cardenal Herrera UniversityHospital Politècnic i Universitari la Fe de ValènciaRecrutementFracture de la hanche | Délire - PostopératoireEspagne